XOMA Royalty Corporation Announces Cash Dividends for Holders of Series A and Series B Cumulative Preferred Stock
EMERYVILLE, Calif., March 20, 2025 – XOMA Royalty Corporation (Nasdaq: XOMA) has recently made an important announcement regarding cash dividends for holders of its Series A and Series B Cumulative Preferred Stock. The Board of Directors has authorized the distribution of these dividends, which is a positive sign for investors in the biotech industry.
Details of the Dividend Announcement
According to the press release, the exact dividend amounts and payment dates have not been disclosed at this time. However, the announcement indicates that the dividends will be paid in cash, and XOMA Royalty intends to provide further details in the coming weeks. The dividend payments will be made to holders of record as of a specified date, which will also be announced in due course.
Impact on XOMA Royalty Shareholders
For XOMA Royalty shareholders, this dividend announcement is a welcome development. Cumulative preferred stockholders are entitled to receive dividends before common stockholders, ensuring a more stable and consistent return on investment. This dividend payout could provide a significant boost to investors’ portfolios and demonstrate XOMA Royalty’s financial strength.
Global Implications
The biotech industry as a whole could benefit from this dividend announcement, as it may indicate a trend towards increased stability and profitability in the sector. The dividend payout could also attract more investors to XOMA Royalty and the biotech industry, further driving growth and innovation.
Further Information
For those interested in learning more about XOMA Royalty Corporation and its dividend policy, the company’s website (
Conclusion
XOMA Royalty Corporation’s announcement of cash dividends for holders of its Series A and Series B Cumulative Preferred Stock is a positive development for the biotech industry and its investors. The dividend payout could provide a significant boost to shareholders and demonstrate XOMA Royalty’s financial strength. Furthermore, this trend towards increased stability and profitability in the biotech sector could attract more investors and drive growth and innovation. Stay tuned for further details on the dividend amounts and payment dates.
- XOMA Royalty Corporation announces cash dividends for Series A and Series B Cumulative Preferred Stock holders
- Dividends will be paid in cash, with further details to be announced
- Impact on XOMA Royalty shareholders: stable and consistent return on investment
- Global implications: positive trend for the biotech industry
- For more information: XOMA Royalty website and financial news outlets
